Navigation Links
Innocuous intestinal bacteria may be reservoir for resistance

"Harmless" bacteria in the digestive tracts of dairy cows, may not be so harmless after all. They may be a reservoir for antibiotic resistance genes that can be transferred to more harmful, disease-causing bacteria, according to research presented today at the 106th General Meeting of the American Society for Microbiology in Orlando, Florida.

"There is concern that veterinary therapeutic usage of antibiotics in animals is responsible for the emergence of drug-resistant Salmonella. For dairy farms recently surveyed in Georgia, there was no association found between antibiotic use and isolation of multi-drug resistant Salmonella. Where does the drug resistance in Salmonella originate?" says Susan Sanchez of the University of Georgia, who conducted the study with other researchers from the University of Georgia and the Universidad Complutense of Madrid.

Using DNA-based technology Sanchez and her colleagues discovered that a significant number of non-pathogenic, commensal bacteria isolated from cow manure contain the same antibiotic-resistance genes as those found in multi-drug resistant Salmonella strains found on the same farm. In addition, isolation of antibiotic-resistant Salmonella appears to be associated with whether or not commensal bacteria carry these resistance genes rather than antibiotic use on the farm.

"This work suggests that mobile DNA elements like plasmids are responsible for the rapid spread of drug resistance on farms. Ecology appears to play a more important role in the emergence of drug resistance in Salmonella than therapeutic antibiotic use," says Sanchez.


'"/>

Source:American Society for Microbiology


Page: 1

Related biology news :

1. Highly adaptable genome in gut bacterium key to intestinal health
2. NSAID drug protects against intestinal tumors in mice, despite poor diet and gene losses
3. Stanford gut check shows diversity of intestinal ecosystem
4. Gut protein found to protect against infection and intestinal breakdown
5. Transgenic goats milk offers hope for tackling childrens intestinal disease
6. Bacterial protein shows promise in treating intestinal parasites
7. Like a snail through the intestinal canal
8. Cow protein aids in treatment of gastrointestinal disorder
9. Anti-bacterial additive widespread in U.S. waterways
10. A bacterial genome reveals new targets to combat infectious disease
11. Discovery of key proteins shape could lead to improved bacterial pneumonia vaccine
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:5/12/2016)... , May 12, 2016 WearablesResearch.com ... just published the overview results from the Q1 wave ... the recent wave was consumers, receptivity to a program ... data with a health insurance company. "We ... to share," says Michael LaColla , CEO of ...
(Date:5/3/2016)... 3, 2016  Neurotechnology, a provider of high-precision ... Automated Biometric Identification System (ABIS) , a complete ... MegaMatcher ABIS can process multiple complex biometric transactions ... of fingerprint, face or iris biometrics. It leverages ... and MegaMatcher Accelerator , which have been ...
(Date:4/28/2016)... -- First quarter 2016:   , Revenues ... first quarter of 2015 The gross margin was 49% ... and the operating margin was 40% (-13) Earnings per ... from operations was SEK 249.9 M (21.2) , Outlook ... 7,000-8,500 M. The operating margin for 2016 is estimated ...
Breaking Biology News(10 mins):
(Date:6/27/2016)... 27, 2016 /PRNewswire/ - BIOREM Inc. (TSX-V: BRM) ("Biorem" or ... its major shareholders, Clean Technology Fund I, LP and ... based venture capital funds which together hold ... a fully diluted, as converted basis), that they have ... entire equity holdings in Biorem to TUS Holdings Co. ...
(Date:6/27/2016)... ... 2016 , ... Parallel 6 , the leading software as a service ... Virtual Patient Encounter CONSULT module which enables both audio and video telemedicine communication ... , Using the CONSULT module, patients and physicians can schedule a face to face ...
(Date:6/27/2016)...  Liquid Biotech USA , ... Sponsored Research Agreement with The University of Pennsylvania ... cancer patients.  The funding will be used to ... clinical outcomes in cancer patients undergoing a variety ... employed to support the design of a therapeutic, ...
(Date:6/24/2016)... 24, 2016 Epic Sciences unveiled a ... susceptible to PARP inhibitors by targeting homologous recombination ... The new test has already been incorporated into ... cancer types. Over 230 clinical trials ... pathways, including PARP, ATM, ATR, DNA-PK and WEE-1. ...
Breaking Biology Technology: